WHO ICTRP trial
To evaluate the efficacy and safety of dust mite-specific immunotherapy in…
ChiCTR2500100179 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500100179 |
|---|---|
| Public title | To evaluate the efficacy and safety of dust mite-specific immunotherapy in allergic rhinitis: A multi-center, open, prospective, Randomized Controlled Clinical Trial (Tonsil-AIT) |
| Scientific title | To evaluate the efficacy and safety of dust mite-specific immunotherapy in allergic rhinitis: A multi-center, open, prospective, Randomized Controlled Clinical Trial (Tonsil-AIT) |
| Primary sponsor | The First Affiliated Hospital of Nanchang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Allergic Rhinitis |
| Interventions | One-strength group:Subcutaneously inject Bottle No. 3 mite allergen preparation into the upper limb according to the instructions.;ITIT-A group:Referencing the literature, inject Bottle No. 1, 2, and 3 mite allergen preparations into the… |
| Registration date | Apr 3, 2025 |
| Target size | One-strength group:118;ITIT-A group:118;ITIT-B group:118 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: